Long-term outcome of a covered vs. uncovered transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome

Liver International

Volumn 28, Issue 2, 2008, Pages 249-256

  Murad, Sarwa Darwish ^a   Luong, Trinh K ^a   Pattynama, Peter M T ^a   Hansen, Bettina E ^a   Van Buuren, Henk R ^a   Janssen, Harry L A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Budd Chiari syndrome; Hepatic vein thrombosis; Portal hypertension; Stents; Transjugular intrahepatic portosystemic shunt

Indexed keywords

POLITEF;

ADULT; ARTICLE; BUDD CHIARI SYNDROME; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; LIVER TRANSPLANTATION; MALE; MORTALITY; OUTCOME ASSESSMENT; PORTOSYSTEMIC ANASTOMOSIS; PROGNOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; STENT; SURVIVAL TIME;

ADULT; BUDD-CHIARI SYNDROME; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYTETRAFLUOROETHYLENE; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RETROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 38949083895     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2007.01649.x     Document Type: Article

References (16)

1. Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC. Budd-Chiari syndrome: A review by an expert panel. J Hepatol 2003; 38: 364-71.
2. Senzolo M, Cholongitas EC, Patch D, Burroughs AK. Update on the classification, assessment of prognosis and therapy of Budd-Chiari syndrome. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 182-90.
3. Ruh J, Malago M, Busch Y, et al. Management of Budd-Chiari syndrome. Dig Dis Sci 2005; 50: 540-6.
4. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9.
5. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.
6. Zeitoun G, Escolano S, Hadengue A, et al. Outcome of Budd-Chiari syndrome: A multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology 1999; 30: 84-9.
7. Langlet P, Escolano S, Valla D, et al. Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J Hepatol 2003; 39: 496-501.
8. Murad SD, Valla DC, de Groen PC, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 2004; 39: 500-8.
9. Valla DC. The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies. Hepatology 2003; 38: 793-803.
10. Menon KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med 2004; 350: 578-85.
11. PerellóA, Garcia-Pagan JC, Gilabert R, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology 2002; 35: 132-9.
12. Hernandez-Guerra M, Turnes J, Rubinstein P, et al. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology 2004; 40: 1197-202.
13. DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002; 22: 27-42.
14. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-71.
15. Rössle M, Olschewski M, Siegerstetter V, Berger E, Kurz K, Grandt D. The Budd-Chiari syndrome: Outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery 2004; 135: 394-403.
16. Mancuso A, Fung K, Mela M, et al. TIPS for acute and chronic Budd-Chiari syndrome: A single-centre experience. J Hepatol 2003; 38: 751-4.